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A B S T R A C T
Eighty-five percent of the incidents and deaths from cervical cancer occur in low and middle income countries.
In many of these countries, this is the most common cancer in women. The survivals of the women with gy-
necologic cancers are hampered by the paucity of prevention, screening, treatment facilities and gynecologic
oncology providers. Increasing efforts dedicated to improving education and research in these countries have
been provided by international organizations. We describe here the existing educational and research programs
that are offered by major international organizations, the barriers and opportunities provided by these colla-
borations and hope to improve the outcomes of cervical cancer through these efforts.
1. Introduction
Globally, cervical cancer affects more women than any other gy-
necologic malignancy. It is the fourth most common malignancy overall
and, in half of the sub-Saharan countries, it is the most common cancer
in women (Small Jr et al., 2017). Despite efforts to improve the care of
women with cervical cancers in low- and middle-income countries
(LMIC), there remain significant treatment access gaps. In order to
make meaningful changes, well-organized education and training for
gynecologists in LMIC is urgently needed. Examples of such initiatives
include the successful implementation of a curriculum for resident
education based on the Council for Resident Education in Obstetrics
and Gynecology (CREOG) residents in Central America (Schmeler et al.,
2013), the training of physicians by The Society of Gynecologic
Oncology of Canada to perform radical hysterectomy for women with
cervical cancers through a teaching module in Kenya(Rosen et al.,
2017), and a collaborative effort between the Society of Gynecologic
Oncology (SGO), American Society of Clinical Oncology (ASCO) and
Health Volunteers Overseas (HVO) in the development of education and
surgical training in Honduras and Vietnam (Chuang et al., 2014). This
paper describes the efforts focused on improving women's cancer care
outcomes through education, training and research that are carried out
by major organizations around the world.
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mission is to reduce the burden of cancer in Africa by promoting and
implementing cancer control efforts through research and training in
cancer, thereby eliminating pain and suffering for millions of people
(Ogunbiyi et al., 2016). AORTIC's plan of action and research agenda
serves to encourage, support, integrate, and facilitate evidence-based
interventions and innovative projects and initiatives in all areas across
the spectrum of cancer control, thus ensuring that cancer in Africa is
firmly on the continent's health agenda. AORTIC achieves these goals
by working with other international agencies and non-profit organiza-
tions, government agencies, health care industries and businesses to
advocate for improved resources and access to care.
With these goals in mind, a wide spectrum of activities was in-
stigated by AORTIC. These include developing and implementing
National Cancer Control Programs; supporting the development of
standardized training programs in all aspects of cancer care and man-
agement; facilitating and promoting research in cancer that is relevant
to the African continent; providing relevant and accurate information
on the prevention, early diagnosis, treatment, and palliative care to
health care professionals, media and the public; creating awareness of
the extent of cancer in Africa and reducing the stigma associated with
the disease. Peripheral activities include support for the management
and funding of training programs in oncology with member institutions
and elsewhere; organization of symposia, workshops, meetings and
conferences. They assist in the formation of cancer research programs
that are relevant in Africa; facilitate international collaborations in
cancer research; arrange or sponsor periodic lectures by distinguished
scholars in oncology. They foster collaboration with existing organi-
zations interested in neoplastic diseases and facilitate the im-
plementation of relevant and appropriate research on cancer. AORTIC
is working to establish or assist in the creation of journals and pub-
lication of monographs and oncology books for the dissemination of
research work on cancer in Africa. The organization provides scholar-
ship and grants to facilitate objectives; and offers technical advice to the
World Health Organization, the African Union, and other Governments
in Africa on Cancer related issues.
3. ASCO
ASCO International (https://www.asco.org/international-
programs) was developed with a goal of improving cancer care
through the dissemination of knowledge in oncology around the world
(Saghir et al., 2013). With regards to LMIC, ASCO has programs focused
on improving the quality of cancer care through training, guidelines
and quality measurements tools, professional development and re-
search (Hortobagyi et al., 2016). For care delivery, ASCO offers re-
source-stratified guidelines and trainings in multidisciplinary cancer
management course, palliative care and cancer prevention and
screening (Chuang et al., 2016a). International education courses in-
cluding a multidisciplinary cancer management course (MCMC) pro-
mote a multidisciplinary effort in cancer management through educa-
tion. A palliative care course focuses on end of life care for oncology
patients, a course in cancer control in primary care provides training for
clinicians and nurses in the prevention, screening and survivorships of
oncology patients. Many of these trainings are done through ASCO's
International Cancer Corps (ICC), created through collaboration with
HVO and SGO to send volunteer members to contribute to the im-
provement of cancer care capacities in LMIC (Chuang et al., 2014).
Programs are available in Honduras, Vietnam, Bhutan, and Nepal, with
additional sites in Ghana and Uganda expected to start in 2018. and
ASCO's Conquer Cancer Foundations offers research funding through
International Innovational Grants, which are one-year grants of
$20,000 each to support research projects targeted at low-resource
settings. In 2017, the Foundation also launched a new Young In-
vestigator Award for Global Oncology to support novel research in
cancer care in resource-limited settings. Scholarships, short (Interna-
tional Development and Educational Awards, IDEA award) or long term
(Long-Term International Fellowships, LTIF), are provided for early-
career oncologists to attend ASCO meetings or to conduct research with
mentors from North America. A Global Curriculum jointly developed by
ASCO and European Society of Medical Oncology provides global
education guidelines that are required for physicians to qualify as
medical oncologists. An In-training examination (ITE) has been set up
to help assess clinical knowledge of the trainees in medical oncology.
Many of the courses and opportunities are available at no cost to on-
cologists practicing in LMIC.
4. Cervical cancer research network (CCRN)
CCRN was established in 2011.This initiative emerged from the
state of the art symposium on cervical cancer held in Manchester in
2009 (Suneja et al., 2015). The attendees supported two trial concepts
which subsequently led to two Gynecologic Cancer InterGroup (GCIG)
international randomized phase III trials in locally advanced cervical
cancer. The greatest disease burden is in LMIC where national research
groups are yet to be established and are without representation to the
GCIG. The CCRN was established as an umbrella for such groups under
the overall management of the GCIG to facilitate participation in es-
tablished GCIG studies.
A multidisciplinary group of international clinicians agreed to a
framework for assessing and evaluating potential sites for CCRN ac-
creditation. Radiotherapy (RT) is an essential component in the overall
management of many women with this disease and therefore it was
mandatory that sites should have access to it. A document for assess-
ment of the RT capabilities was developed and collated by the
Radiologic Physics Centre in Houston, Texas. It was deemed essential
that all sites participate in a beam measurement program every 2 years.
Potential sites are asked to complete a pre-qualifying questionnaire on
the disease burden, hematology, pathology and radiology resources and
technology support. This information is reviewed by the CCRN execu-
tive. Assuming the agreed criteria are met, a site visit with a compre-
hensive review of facilities and capabilities is arranged.
It has become clear that the barriers to participation in clinical re-
search in LMIC are multifactorial, but not insurmountable, if appro-
priate monetary funds were available. In addition to the funds required
for the basic clinical trial infrastructure, it is necessary to address the
reimbursement for the cost of the “standard of care treatment” and the
additional costs incurred by the institution in delivering the trial. This
prohibits many academic studies from participating in LMIC without a
per-patient reimbursement. Many LMIC do not have appropriate in-
demnity insurance at an institutional and individual level to satisfy
many international trial sponsors. The challenge is to develop a me-
chanism whereby sites could receive assistance to address these issues.
This would probably need to be on a competitive basis and for a defined
period of time. The criteria could include a proposal to address a par-
ticular unmet research need in their geographical area.
It would be naive to assume that all the barriers can be overcome
with money, and care should be taken to ensure that cultural and
ethical issues are addressed. Overcoming these less visible barriers
through education may be the ultimate key to the success or failure of a
study. Communication between clinicians from different parts of the
world facilitates an exchange of information and ideas and this un-
derpins the annual regional symposia organized by CCRN. These sym-
posia aim to bring together multidisciplinary teams involved in the
treatment of cervical cancer in a defined geographical region. Attendees
are sponsored by CCRN and actively participate in workshops and
tumor boards over a 2-day period. Engagement with local community
elders and women's groups is likely to be essential to disseminate the
information to those less well-educated members of the community and
to win their trust. Such relatively easy and affordable initiatives are
essential to compliance with treatment and follow up and are central to
the success of clinical trials. The challenge is to assist the local clinicians
and policy makers in coming together to improve the outcome for
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women with cervical cancer and educating their friends and family on
how and when to seek medical advice. The onus is on clinicians to lead
the way.
Over the past 6 years CCRN has engaged with many interested
clinical groups in LMIC and successfully facilitated participation by
non-GCIG groups in 3 international GCIG trials. Our challenge for the
future is to build on this success through enhanced recruitment and to
encourage and mentor groups in LMIC to design and conduct trials
appropriate to their particular needs.
5. European Society of Gynecologic Oncology (ESGO)
ESGO is promoting a common training curriculum/program, setting
minimum standards and providing a system of accreditation (and re-
accreditation) for gynecological oncology (GO) training centers across
Europe. GO remains unrecognized as an independent sub-specialty in
many European countries (Manchanda et al., 2013). ESGO offers a
number of 3month Travelling Fellowships to European trainees with
particular emphasis being placed on proposals from European countries
(UMIC/LMIC), with restricted access to funding and technology. The
fellowships aim to improve patient outcomes through training and re-
search, sharing knowledge/technologies and increasing mobility be-
tween European countries. International (non-UK/Dutch) trainees who
complete training at a UK/Royal College of Obstetrics and Gynecology
(RCOG) or Netherlands/Netherlandse Vereniging voor Obstetrie &
Gynaecologie (NVOG) accredited centers can apply for the ESGO Cer-
tificate of European Accredited Gynecological Oncologist. The Eur-
opean Network of Young Gynecological Oncologists (ENYGO) is a vi-
brant (https://enygo.esgo.org/) network of ~700 European trainees
which promotes training, building research competencies, educational
needs, engagement and social interaction between European GO trai-
nees. The group has undertaken numerous initiatives to improve the
quality of GO training, including workshops, master classes, establish-
ment of web-based resource (e-academy) and involvement of trainees in
the accreditation process. The ESGO e-academy serves as an important
educational resource for GO trainees and provides regularly updated
educational content including CME Accredited Courses in GO (https://
enygo.esgo.org/watch/ecme-courses/). ESGO promotes and facilitates
research activity across European countries through its networks and
task forces. These include: ENGOT (European Network of Gynecological
Oncological Trial groups); ENTRIGO (European Network of Transla-
tional Research in Gynecological Oncology); ENITEC (European Net-
work of Individualized Treatment in Endometrial Cancer); INCIP (In-
ternational Network on Cancer, Infertility and Pregnancy) and EOTTD
(European Organization for Treatment of Trophoblastic Diseases). The
RCOG has fellows and members across 106 countries. It supports edu-
cation, training and research in Women's Health across LMIC, LIC and
Upper Middle Income (UMIC) countries through its Global Health
Strategy. (https://www.rcog.org.uk/globalassets/documents/global-
network/global-health-strategy/rcog_global_health_strategy_2013-17.
pdf). The RCOG has held specialist training workshops/courses in
several Eastern-European and central-Asian countries. A Medical
Training Initiative (MTI) scheme provides training opportunities to
International Medical Graduates (IMGs) in the form of the International
Doctors' Training Program (IDTP). While the MTI scheme is directed
towards general Obstetrics and Gynecology training, the RCOG is in-
vestigating opportunities for sub-specialty training and non-clinical
internships, sponsored by a doctor's home country and the RCOG. The
BGCS (British Gynecological Cancer Society) supports the RCOGs
Global Health Strategy and is working with the RCOG towards im-
proving cancer outcomes within this strategy. The BGCS supports the
IGCS Gynecologic Oncology Global Curriculum & Mentorship Program
(Chuang et al., 2016b). This is running across four pilot sites. A number
of UK institutions have expressed interest in mentoring and supporting
GO centers in other LIC/MIC countries and implementing this global
GO curriculum. As this program expands, other opportunities for
collaborative training and research between the UK and other LIC/MIC
countries should grow. Grant funding from UK Research Councils/the
UK Government and LIC/MIC national institutions facilitate colla-
borative research between UK and other LIC/MIC countries (for e.g. the
United Kingdon and India Research Initiative, UKIERI). This has led to
ongoing collaborations in research and training within the UK and
between UK and other countries. These include Barts Health Royal
London Hospital /Queen Mary University of London and Gateshead/
Newcastle University and Indian Institutions like All India Institute of
Medical Sciences, Tata Memorial Hospital Kolkata and AGOI (Associa-
tion of Gynecological Oncologists of India).
6. International Federation for Gynecology & Obstetrics (FIGO)
FIGO (https://www.figo.org/) is the only global organization that
brings together professional societies of Obstetricians & Gynecologists.
FIGO's vision is for women to achieve highest possible standards of
physical, mental, reproductive and sexual wellbeing throughout their
lives. For more than 60 years, FIGO has collaborated with the world's
top health and donor bodies, and has member societies in 130 nations/
territories.
The FIGO Gynecologic Oncology Committee is one of nine com-
mittees in FIGO. It has a special interest in gynecologic oncology and
comprises 10 members representing the various regions of the world,
encompassing gender and ethnic diversity, and a multidisciplinary re-
presentation of the various specialties that work hand in hand towards
the care of women with gynecologic cancers, situational analyses of
cancers, publications and awareness programs.
FIGO was the first to establish the staging system for cancers in
1929. Unlike other cancers that use Tumor/Nodes/Metastasis classifi-
cations of malignant tumors (TNM) staging systems, gynecologic can-
cers continue to be staged by FIGO staging systems. FIGO is sensitive to
different resources in various parts of the world and the need to have
equal participation and access from less resourced countries. The sta-
ging of cervical cancer, mainly a disease of low resource regions, con-
tinues to be done clinically with only very basic investigations, while
staging of endometrial and ovarian cancers is determined surgico-
pathologically. From time to time, these systems are updated in the
light of new literature and advances. The cervical cancer staging is
being reviewed to incorporate modern imaging methods. The FIGO
Cancer Report is a three-yearly publication brought out at each FIGO
conference and, in order to reach a wider audience, the last issue of
Report was available in Spanish and Portuguese.
The Gynecologic Oncology Committee works in close collaboration
with other associated committees including the Education Committee,
and the Working Groups in improving education and awareness. The
Committee has endorsed and contributed to the development of an e-
learning course on cervical cancer prevention using HPV vaccines and
screening in collaboration with the Catalan Institute of Oncology (ICO).
The course is available in English, Spanish, Portuguese, French,
Japanese, Chinese, Italian and Greek, and others are in preparation.
Among its forthcoming activities, the Committee will conduct a
half-day Workshop at the FIGO Regional Conference in Dubai in April
2018 that will focus on imparting skills in various techniques to gy-
necologists. The role of obtaining accurate data to inform decisions on
staging and management is critical. However, data from LMIC is scarce
and incomplete. The FIGO Gynecologic Oncology Committee welcomes
suggestions and partnership from like-minded organizations, institu-
tions and donors who can help in systematic data collection on situa-
tional analyses of the various cancers as it seeks to further its mission of
providing equitable health care for the prevention and treatment of
gynecological cancers.
7. International Gynecologic Cancer Society (IGCS)
IGCS (https://igcs.org/) was established as a not-for-profit
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organization in 1987. IGCS was intended to create an equal partnership
of gynecologic, radiation, and medical oncologists, pathologists, and
other scientists from around the world who devote their professional
lives to the care of women with gynecologic cancer. The mission of the
IGCS is to enhance the care of women with gynecologic cancer world-
wide through education and training and public awareness. This is
achieved through collaborations, meetings, publications, outreach,
providing education and training worldwide.
The Gynecologic Oncology Global Curriculum & Mentorship
Program (GOGCMP):
In 2017, the IGCS developed and launched the GOGCMP. This
program was developed in response to the problem that many regions
of the world still do not have specialty training in gynecologic on-
cology, leaving women without the specialty care they need for the
prevention and treatment of cervical cancer and other gynecologic
malignancies. The program consists of a comprehensive two-year edu-
cation and training program designed for those regions around the
world that do not have formal training in gynecologic oncology. The
program matches institutions and individuals from higher resource
settings with partners in lower resource settings wishing to obtain
formal gynecologic oncology training (twinning). The specific goals of
the program are:
• Develop and maintain a comprehensive two-year web-based curri-
culum for local gynecologic oncology training and education that
can be adapted by each region/program to reflect local needs and
facilities.
• Select trainees from lower resource settings (gynecologic oncology
fellows) and pair them with local supervisor(s) from their home
program as well as gynecologic oncologist(s) from a mentoring in-
stitution (international mentor(s)).
• Establish minimum requirements for the gynecologic oncology fel-
lows to complete the program and receive a certificate following an
examination and completion of the two-year training program.
• Hold monthly tumor boards using Project ECHO where the fellows,
local supervisors and international mentors review cases and parti-
cipate in ongoing learning and mentoring opportunities.
• Establish a program for the international mentor(s) to travel to the
fellow institution at regular intervals for hands-on surgical training
and in-person teaching.
• Facilitate and support the fellows' travel to the mentoring institution
for up to three months for training and education.
The IGCS has launched four pilot sites (Vietnam, Mozambique,
Ethiopia and Kenya) in 2017 to implement the GOGCMP. There are
plans to expand the GOGCMP to additional sites around the world in-
terested in accessing specialty training in gynecologic oncology. These
include Guatemala, Liberia, West Indies and Fiji. The IGCS is interested
in developing similar parallel programs in radiation oncology and in the
diagnosis and management of pre-invasive cervical disease.
8. National Cancer Institute (NCI)
The U.S. National Cancer Institute's Center for Global Health (NIH
CGH) was established in 2011 to coordinate the response of the NIH to
the growing burden of cancer in LMIC·(Varmus and Trimble, 2011) The
mission of the CGH is threefold: 1) strengthening global cancer research
and resource-appropriate cancer control strategies, 2) building a global
cancer community, and 3) translating research results into practice. In
keeping with these priorities, the CGH works with policy makers and
other stakeholders to develop partnerships to support national cancer
strategies, including support of the International Cancer Control Part-
nership and regional Cancer Control Leadership Forums. Other in-
itiatives by the CGH include the Partnerships for Enhanced Engagement
in Research (PEER), an implementation science master course, and
short courses in research skills and cancer epidemiology. The CGH has
offered funding opportunities that have been effectively applied to
gynecologic cancer control projects in LMIC, including the ‘Cancer
Detection, Diagnosis, and Treatment Technologies for Global Health
program in partnership with the National Institute of Biomedical Ima-
ging and Engineering. In addition, there is a recent initiative to support
regional centers of research excellence in non-communicable diseases
and injuries. The National Cancer Institute partners with the Fogarty
International Center to create opportunities for research training and
project support for both U.S. and international scholars working in
LMIC through competitive opportunities such as the ‘Emerging Global
Leader Award K43 program’. (https://www.fic.nih.gov/Programs). The
Fogarty International Center offers specific funding opportunities in
areas pertaining to gynecologic cancer control, such as mHealth, in-
formatics, and the non-communicable diseases and injury program. The
CGH has been supporting the building of a global cancer research
community through collaborative international meetings such as
meetings in gynecologic oncology held in Belarus and in Kazakhstan
with the IGCS and aligned national and regional cancer centers. The
CGH seeks to work through these developing partnerships, such as with
professional societies and the newly developing non-communicable
disease (NCD) Regional Centers for Research Excellence, which will
establish a network of regional hubs in LMIC to coordinate NCD, injury
and disability research.
9. Moving forward
International professional organizations are uniquely positioned to
lead the education and training in healthcare providers in LMIC for
women with gynecologic cancers (Table 1). The strengths of these or-
ganizations include their robust infrastructure and experience in deli-
vering clinical training and research over the past few decades. Edu-
cation has been the primary cornerstone of their programs. These
programs exist in the forms of meetings, workshops, on site trainings,
research development to clinical trials. Global curricula were estab-
lished by ASCO, ESGO and IGCS that provide guidance on formal
learning and training in gynecologic oncology. One of the barriers to
these programs was the development of training programs that are
based on these curricula. IGCS has established the formal mentorship
program that permits gynecologic oncologists from established centers
to travel to LMIC to train clinicians to provide care for women with
gynecologic cancers. To supplement these efforts, ASCO and SGO col-
laborate with HVO to send volunteers to help with capacity building in
existing gynecologic oncology programs. In order to further advance
the care in LMIC, research capacity building is vital. ASCO, AORTIC,
NCI, ESGO, CCRN and AGOG provide research supports in training,
projects and funding. While much of the training in research is con-
ducted on sites in LMIC, grants are provided for researchers from LMIC
to learn on sites in centers where clinical trials are being conducted.
More formal grant opportunities are available through the NCI.
10. Conclusions
Over the years, several key areas have been identified to ensure
advancement in gynecology oncology care and research. This includes
formalized gynecologic training programs and enhancement of existing
training programs, research capacity building through workshops, on-
site training and research grant opportunities. LMIC are in need of
oncologists who can provide cancer care to women with gynecologic
and other cancers. The list of international organizations described in
this paper is likely to be incomplete as many other organizations and
universities are contributing to the training and research in gynecologic
oncology in LMIC. Our review provides a comprehensive description of
the existing educational and research programs that are offered by
major international organizations. The efforts of these organizations in
collaborations with centers in LMIC will help build sustainable pro-
grams in LMIC that will enhance the mission of improving education,
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training and research in gynecologic cancers around the world.
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Table 1




AORTIC To improve cancer control in Africa through the facilitation of research and
training and the provision of relevant and accurate information on the prevention,
early diagnosis, treatment, and palliation of cancer
Education, training, meetings and scholarships
ASCO To provide the highest-quality resources in education, policy, the pioneering of
clinical research and advancing the care for patients with cancer
Education, global curriculum, in-training examinations,
workshops, meetings, research grants, volunteering through HVO
and scholarships
CCRN To promote high quality research performed in LMIC where there is a significant
need with the goal of improving the care of women with cervical cancer
worldwide
Education, symposium, research and clinical trial developments
ESGO To improve the health and well-being of European women with gynecological
(genital and breast) cancers through prevention, excellence in care, high quality
research and education
Education, workshops, clinical trials, meetings and scholarships
FIGO To achieve the highest possible standards of physical, mental, reproductive and
sexual health and wellbeing through their lives.
Education, training, research, meetings, and guideline
developments
IGCS To enhance the care of women with gynecologic cancer worldwide through
education and training and public awareness
Education, global curriculum and mentorship training programs,
meetings and public awareness
NCI To conduct research and provide grants in cancer controls globally Education, research, grants, fellowships and guideline
developments
AOFOG To promote the science and art of obstetrics, gynecology and reproductive biology Education, workshops and training.
ASGO To conduct study, prevent and improve treatment of gynecologic cancer Education, meetings, scholarships and publications
AGOG To promote the understanding, prevention and to improve the quality of care in
gynecologic cancer in Asia and the world
Education, research and clinical trials
SGO To promote excellence in the care of women at risk for or affected by gynecologic
cancer through advocacy, education, research and inter- disciplinary
collaboration
Education, meetings, research, international collaborations,
scholarships, international volunteer through HVO and
publication
Abbreviations: AORTIC, African Organization in Research and Training in cancer; ASCO, American Society of Clinical Oncology; HVO, Health Volunteer Overseas;
CCRN. Cervical Cancer Research Network; ESGO, European Society of Gynecologic Oncology; FIGO, International Federation of Gynecology and Obstetrics; IGCS,
International Gynecologic Cancer Society; NCI, National Cancer Institute; AOFOG, Asia and Oceania Federation of Obstetrics and Gynecology (www.aofog.org/
about-aofog); ASGO, Asian Society of Gynecologic Oncology (http://www.asiansgo.org/); ASGO, Asian Gynecologic Oncology Group; AGOG, Asian Gynecologic
Oncology Group (http://www.agog.org.tw/); SGO, Society of Gynecologic Oncology.
L. Chuang et al. Gynecologic Oncology Reports 25 (2018) 65–69
69
